Pharmafile Logo
Pharmafocus logo
Advanced Search

Qnexa

Showing 4 posts of 4 posts found.

FDA image

FDA clears Arena and Eisai’s obesity drug

June 28, 2012
Sales and Marketing Arena, Belviq, Eisai, FDA, Qnexa, Roche, obesity

Eisai and Arena’s Belviq has gained FDA approval, making it the first obesity drug to be approved in over ten …

News
FDA picture

Obesity drugs vie for approval as FDA panel backs lorcaserin

May 14, 2012
Research and Development, Sales and Marketing Arena, Eisai, FDA, Qnexa, lorcaserin, obesity

An FDA panel has recommended Arena’s obesity drug lorcaserin, setting up a showdown with Vivus’ Qnexa. Qnexa was recommended by an FDA panel …

News
FDA picture

Obesity drug supported by FDA panel

February 23, 2012
Sales and Marketing FDA, Qnexa, Vivus, Xenical, obesity

Vivus’ obesity drug Qnexa has been supported by an FDA panel, two years after it was knocked back by the …

News
Obesity

Takeda obesity drug falters at phase II

March 18, 2011
Research and Development Alli, Amylin, Contrave, Meridia, Qnexa, Takeda, Xenical, lorcaserin, metreleptin, obesity, pramlintide

Yet another investigational drug appears to have faltered on the rocky path to develop anti-obesity treatments. Takeda Pharmaceutical Company and …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025